Vaxcyte (PCVX) Enterprise Value Growth (1y) (2020 - 2026)
Vaxcyte (PCVX) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vaxcyte | 7.76 Bn | 7.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.91% |
| Dec 31, 2025 | 10.66% |
| Sep 30, 2025 | 21.52% |
| Jun 30, 2025 | -14.37% |
| Mar 31, 2025 | -12.46% |
| Dec 31, 2024 | -61.74% |
| Sep 30, 2024 | -72.28% |
| Jun 30, 2024 | -12.87% |
| Mar 31, 2024 | -80.83% |
| Dec 31, 2023 | -15.98% |
| Sep 30, 2023 | -249.42% |
| Jun 30, 2023 | -263.07% |
| Mar 31, 2023 | -145.65% |
| Dec 31, 2022 | -278.65% |
| Sep 30, 2022 | -30.03% |
| Jun 30, 2022 | -21.36% |
| Mar 31, 2022 | -4.21% |
| Dec 31, 2021 | 36.31% |
| Sep 30, 2021 | 29.84% |
| Jun 30, 2021 | 28.76% |